Clinical Efficacy of Long-Acting β2 Agonists and Long-Acting Muscarinic Antagonist for Moderate to Severe Chronic Obstructive Pulmonary Disease
Crossref DOI link: https://doi.org/10.1007/s11094-023-02891-4
Published Online: 2023-06-21
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xu, Yongqian
Pang, Yu
Text and Data Mining valid from 2023-06-21
Version of Record valid from 2023-06-21
Article History
Received: 27 July 2021
First Online: 21 June 2023